Suzanne Louise Bruhn

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
10 years
Director since
2023

10 years of board service in total across 3 boards, counting each seat separately. Longest: Travere Therapeutics Inc., 3 years.

3 years · Since 2023
3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 11, 2026 Definium Therapeutics Inc. Grant or award +4,666 — —
May 19, 2026 Travere Therapeutics Inc. Grant or award +4,000 — —
May 15, 2025 Travere Therapeutics Inc. Grant or award +6,500 — —
May 8, 2024 Travere Therapeutics Inc. Grant or award +6,500 — —
Jun 21, 2023 Definium Therapeutics Inc. Grant or award +13,671 — —
May 17, 2023 Travere Therapeutics Inc. Grant or award +4,500 — —

Questions about Suzanne Louise Bruhn

What boards is Suzanne Louise Bruhn on?

Suzanne Louise Bruhn sits on the boards of Definium Therapeutics Inc., Pliant Therapeutics Inc. and Travere Therapeutics Inc.

How long has Suzanne Louise Bruhn served on boards?

Our records show at least 10 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.